Evolv
Kwang-Chul Kwon is an accomplished biologist with a focus on plant molecular biology and significant leadership experience in biotechnology. Currently serving as the CTO and Co-founder of Evolv since January 2024, Kwang-Chul previously held the position of Chief Scientific Officer at XiliX MaterialBio, where efforts were concentrated on chloroplast engineering technology and developing FDA-grade SOPs. Prior to this, Kwang-Chul was the CSO at Microsynbiotix, Ltd., specializing in algal chloroplast-based expression systems for oral fish vaccines. Kwang-Chul's academic background includes roles as a Senior Research Scientist at the University of Pennsylvania, where innovative transformation vector systems were developed, and as a Postdoctoral Fellow at the University of Central Florida, focusing on transplastomic plants and their therapeutic applications. The foundational education includes a PhD in Plant Molecular Biology and a BS in Biology, both from Yonsei University.
This person is not in any teams
Evolv
We believe that all humans should have access to solutions that optimize their healthspan and wellbeing. We are a preventative health and longevity company innovating at the intersection of wellness and public health. We leverage cutting-edge molecular and biological science to produce consumer products that are accessible, trustworthy, and undeniably effective. We understand the challenges of living better and longer, we exist to empower you to own your wellbeing journey.